BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38249326)

  • 1. Diagnostic value of [
    Farkas I; Sipka G; Bakos A; Maráz A; Bajory Z; Mikó Z; Czékus T; Urbán S; Varga L; Pávics L; Besenyi Z
    Ther Adv Med Oncol; 2024; 16():17588359231221342. PubMed ID: 38249326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
    Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
    J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Werner P; Neumann C; Eiber M; Wester HJ; Schottelius M
    EJNMMI Res; 2020 May; 10(1):45. PubMed ID: 32382945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA SPECT/CT with
    Schmidkonz C; Goetz TI; Kuwert T; Ritt P; Prante O; Bäuerle T; Goebell P; Cordes M
    Ann Nucl Med; 2019 Dec; 33(12):891-898. PubMed ID: 31502084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial experiences with
    Farkas I; Besenyi Z; Maráz A; Bajory Z; Palkó A; Sipka G; Pávics L
    Orv Hetil; 2018 Sep; 159(35):1433-1440. PubMed ID: 30146905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Australian experience using Tc-PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy.
    Duncan I; Ingold N; Martinez-Marroquin E; Paterson C
    Prostate; 2023 Jul; 83(10):970-979. PubMed ID: 37051636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Dosimetry of
    Urbán S; Meyer C; Dahlbom M; Farkas I; Sipka G; Besenyi Z; Czernin J; Calais J; Pávics L
    J Nucl Med; 2021 Aug; 62(8):1075-1081. PubMed ID: 33277398
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed Imaging Improves Lesion Detectability in [
    Berliner C; Steinhelfer L; Chantadisai M; Kroenke M; Koehler D; Pose R; Bannas P; Knipper S; Eiber M; Maurer T
    J Nucl Med; 2023 Jul; 64(7):1036-1042. PubMed ID: 37230531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPECT-CT Imaging with [99mTc]PSMA-T4 in patients with Recurrent Prostate Cancer.
    Sergieva S; Mangaldgiev R; Dimcheva M; Nedev K; Zahariev Z; Robev B
    Nucl Med Rev Cent East Eur; 2021; 24(2):70-81. PubMed ID: 34382671
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Schmidkonz C; Hollweg C; Beck M; Reinfelder J; Goetz TI; Sanders JC; Schmidt D; Prante O; Bäuerle T; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Prostate; 2018 Jan; 78(1):54-63. PubMed ID: 29105797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Comparison of
    Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
    Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yılmaz B; Şahin S; Ergül N; Çolakoğlu Y; Baytekin HF; Sökmen D; Tuğcu V; Taşçı Aİ; Çermik TF
    Ann Nucl Med; 2022 Jul; 36(7):597-609. PubMed ID: 35426599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hybrid
    Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
    Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraindividual Comparison of
    Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
    Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
    Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
    Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD
    J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry estimation and preliminary clinical application of [
    Yang H; Gao Z; Xu X; Liu C; Hu S; Zhang J; Song S
    Ann Nucl Med; 2023 Jan; 37(1):60-69. PubMed ID: 36346503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Li B; Ding X; Duan L; Shi J; Tang M; Zhang J; Zhao Z; Wu X; Gao Y
    Front Endocrinol (Lausanne); 2024; 15():1326858. PubMed ID: 38449842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.